VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 141 filers reported holding VIKING THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $131,512 | -32.8% | 11,880 | -1.5% | 0.02% | -27.3% |
| Q2 2023 | $195,558 | -4.3% | 12,064 | -1.7% | 0.03% | -15.4% |
| Q1 2023 | $204,379 | +77.1% | 12,275 | 0.0% | 0.04% | +62.5% |
| Q4 2022 | $115,385 | +249.7% | 12,275 | 0.0% | 0.02% | +242.9% |
| Q3 2022 | $33,000 | -5.7% | 12,275 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $35,000 | -5.4% | 12,275 | 0.0% | 0.01% | +16.7% |
| Q1 2022 | $37,000 | -33.9% | 12,275 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $56,000 | -27.3% | 12,275 | 0.0% | 0.01% | -35.7% |
| Q3 2021 | $77,000 | +4.1% | 12,275 | -0.8% | 0.01% | +7.7% |
| Q2 2021 | $74,000 | -5.1% | 12,375 | 0.0% | 0.01% | -13.3% |
| Q1 2021 | $78,000 | +11.4% | 12,375 | 0.0% | 0.02% | +7.1% |
| Q4 2020 | $70,000 | -1.4% | 12,375 | +1.7% | 0.01% | -12.5% |
| Q3 2020 | $71,000 | -17.4% | 12,164 | +1.5% | 0.02% | -23.8% |
| Q2 2020 | $86,000 | +53.6% | 11,980 | 0.0% | 0.02% | +23.5% |
| Q1 2020 | $56,000 | -41.7% | 11,980 | 0.0% | 0.02% | -22.7% |
| Q4 2019 | $96,000 | – | 11,980 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |